$256.15
+1.09%
N/A+$2.77
Healthcare
Drug Manufacturers - General
NYSE
Active Trading
AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio ...
Financial highlights
Latest / TTM · 6 periods
Snapshot
Latest / TTM: 2026-07-22
Gross Margin
—
Net Margin
—
P/E Ratio
—
Debt / Equity
—
Profitability
Profitability table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Gross MarginGross profit as a percentage of revenue. | 69.0% | 70.0% | 62.4% | 70.0% | 70.2% | — |
| Operating MarginOperating income as a percentage of revenue. | 31.9% | 31.2% | 23.5% | 16.2% | 32.8% | — |
| Net MarginNet income as a percentage of revenue. | 20.5% | 20.4% | 9.0% | 7.6% | 6.9% | — |
| EBITDA MarginEBITDA divided by revenue. | 42.6% | 41.6% | 31.6% | 26.5% | 28.8% | — |
| Pre-tax MarginPre-tax profit as a percentage of revenue. | 23.1% | 23.2% | 11.5% | 6.6% | 10.8% | — |
Liquidity & leverage
Liquidity & leverage table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Current RatioCurrent assets divided by current liabilities. | 0.79 | 0.96 | 0.87 | 0.66 | 0.67 | — |
| Quick RatioLiquid assets divided by current liabilities. | 0.70 | 0.84 | 0.76 | 0.55 | 0.56 | — |
| Cash RatioCash and equivalents divided by current liabilities. | 0.28 | 0.31 | 0.34 | 0.14 | 0.12 | — |
| Debt / AssetsDebt as a share of total assets. | 52.9% | 46.2% | 44.6% | 50.2% | 51.6% | — |
| Debt / EquityDebt compared with shareholder equity. | 5.03 | 3.72 | 5.80 | 20.40 | -21.12 | — |
Operating efficiency
Operating efficiency table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Receivables TurnoverHow often receivables are collected in a year. | 5.63x | 5.16x | 4.87x | 5.16x | 4.86x | — |
| Inventory TurnoverHow often inventory is sold in a year. | 5.58x | 4.87x | 4.98x | 4.04x | 3.68x | — |
| Payables TurnoverHow often payables are paid in a year. | 6.05x | 5.94x | 5.54x | 5.74x | 5.07x | — |
| Asset TurnoverRevenue generated per dollar of assets. | 0.38x | 0.42x | 0.40x | 0.42x | 0.46x | — |
| Working Capital TurnoverRevenue generated per dollar of working capital. | -9.56x | -13.92x | -18.37x | -6.26x | -4.47x | — |
Valuation ratios
Valuation ratios table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| P/E RatioPrice paid for each dollar of earnings. | 20.90x | 24.30x | 56.77x | 74.04x | 96.41x | — |
| P/B RatioPrice paid for each dollar of book value. | 15.55x | 16.59x | 26.45x | 94.54x | -124.40x | — |
| P/S RatioPrice paid for each dollar of sales. | 4.26x | 4.93x | 5.04x | 5.58x | 6.65x | — |
| P/FCF RatioPrice paid for each dollar of free cash flow. | 10.90x | 11.80x | 12.42x | 17.63x | 22.83x | — |
| Dividend YieldAnnual dividend divided by current share price. | 3.9% | 3.5% | 3.8% | 3.5% | 2.9% | — |